Location History:
- Richardson, TX (US) (2020)
- Plano, TX (US) (2021)
Company Filing History:
2 out of 5,448 
1 out of 49 Years Active: 2020-2021
Title: Jiyong Lee: Innovator in Cancer Research
Introduction
Jiyong Lee is a prominent inventor based in Richardson, TX (US). He has made significant contributions to the field of cancer research, particularly in developing innovative methods for diagnosing and treating breast cancer. With a total of 2 patents, his work is paving the way for advancements in medical science.
Latest Patents
Jiyong Lee's latest patents include groundbreaking inventions that focus on cancer stem cells. The first patent, titled "Synthetic binder of breast cancer stem cells," provides a novel approach using peptoid compounds that selectively bind to cancer stem cells (CSCs) associated with breast cancer. This invention also contemplates conjugates of the peptoids to detectable labels and therapeutic agents, offering methods for diagnosing and treating breast cancer. The second patent, "FOXC2 inhibitor and methods of use thereof," presents a compound formula and outlines methods for preparing the compound. Additionally, it describes pharmaceutical compositions and methods for treating cancer using the disclosed compound.
Career Highlights
Throughout his career, Jiyong Lee has worked with esteemed institutions such as the University of Texas System and Pohang University of Science and Technology Foundation. His experience in these organizations has contributed to his expertise in cancer research and innovation.
Collaborations
Jiyong Lee has collaborated with notable colleagues, including Luxi Chen and Chao Long. These partnerships have further enhanced his research and development efforts in the field of cancer treatment.
Conclusion
Jiyong Lee's contributions to cancer research through his innovative patents demonstrate his commitment to improving medical outcomes. His work continues to inspire advancements in the diagnosis and treatment of breast cancer.